Gap and risk assessment
Review available product and process knowledge, analytical data, development stage and unresolved scientific risks.
Scientific advisory / Development
Turn a product question into an analytical plan, a clear set of evidence needs and a practical next decision.
The analytical question
Analytical methods need to evolve with the product, process and development stage. Genometrion supports scientific planning and technical assessment across that lifecycle, with a documented rationale for methods, controls and performance expectations. The scope can be a focused question or a connected analytical roadmap.
Potential workstreams
The final scope is agreed for the product, development stage and scientific decision.
Review available product and process knowledge, analytical data, development stage and unresolved scientific risks.
Select candidate technologies, control/reference materials, experiments and prospective performance criteria.
Draft a fit-for-purpose study strategy, with qualification and validation clearly distinguished and justified for the context.
Assess receiving-site needs, documentation, representative samples and transfer or bridging criteria before execution.
Evaluate inconsistent results, deviations and plausible analytical causes; prioritize discriminating follow-up studies.
Support technical reports, protocol or SOP drafts, comparability assessments and method-change rationale.
Consulting deliverables
Depending on the agreed engagement, outputs can include:
These are proposed advisory outputs, not claims of completed experiments or validated performance. Laboratory execution and provider responsibilities are scoped separately.
Genometrion’s website describes consulting and planning scopes. It does not claim in-house testing, completed validation, GMP release activities or regulatory approval. Laboratory work, responsibilities and providers must be agreed separately. ICH guidance is a scientific framework, not company certification.
An initial nonconfidential description of the modality, development stage, analytical question and desired decision is enough to scope a discussion. Confidential materials should follow an agreed exchange arrangement.
No. Transfer needs supporting evidence or a justified alternative appropriate to the method, change and intended use. A readiness review helps identify those needs before laboratory execution.
These sources inform the scientific principles. They do not establish company credentials or endorse Genometrion.
Editorial review: 31 October 2026.
Start with the question
Define the scientific question behind your project. We can discuss the evidence, methods and practical next steps.
Scientific enquiries
A brief, nonconfidential outline is a useful starting point.
contact@genometrion.comEmail GenometrionOpens your email application. Contact details and enquiry guidance.